Related references
Note: Only part of the references are listed.Mechanism, Prevalence, and More Severe Neuropathy Phenotype of the Charcot-Marie-Tooth Type 1A Triplication
Pengfei Liu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
AAV1.NT-3 Gene Therapy for Charcot-Marie-Tooth Neuropathy
Zarife Sahenk et al.
MOLECULAR THERAPY (2014)
THE SHIFTING LANDSCAPE OF GENETIC TESTING FOR CHARCOT- MARIE- TOOTH DISEASE
John D. England
MUSCLE & NERVE (2014)
GENETIC TESTING PRACTICES FOR CHARCOT- MARIE- TOOTH TYPE 1A DISEASE
Renee Tousignant et al.
MUSCLE & NERVE (2014)
Genetics of the Charcot-Marie-Tooth disease in the Spanish Gypsy population: the hereditary motor and sensory neuropathy-Russe in depth
T. Sevilla et al.
CLINICAL GENETICS (2013)
To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations
Rachel C. Wallen et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
A new locus for X-linked dominant CharcotMarieTooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene
Marina L. Kennerson et al.
HUMAN MOLECULAR GENETICS (2013)
Curcumin facilitates a transitory cellular stress response in Trembler-J mice
Yuji Okamoto et al.
HUMAN MOLECULAR GENETICS (2013)
Heterogeneity in the properties of NEFL mutants causing Charcot-Marie-Tooth disease results in differential effects on neurofilament assembly and susceptibility to intervention by the chaperone-inducer, celastrol
Benoit J. Gentil et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2
Michael Gonzalez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Defective Axonal Transport of Rab7 GTPase Results in Dysregulated Trophic Signaling
Kai Zhang et al.
JOURNAL OF NEUROSCIENCE (2013)
Clinical implications of genetic advances in Charcot-Marie-Tooth disease
Alexander M. Rossor et al.
NATURE REVIEWS NEUROLOGY (2013)
Inherited Peripheral Neuropathies
Mario A. Saporta et al.
NEUROLOGIC CLINICS (2013)
Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy
James R. Lupski et al.
GENOME MEDICINE (2013)
Whither Hope for Pharmacological Treatment of Charcot-Marie-Tooth Disease Type 1A?
Pragna I. Patel et al.
JAMA NEUROLOGY (2013)
Cowchock Syndrome Is Associated with a Mutation in Apoptosis-Inducing Factor
Carlo Rinaldi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease
Meiko Hashimoto Maeda et al.
ANNALS OF NEUROLOGY (2012)
Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice
Agnes Patzko et al.
BRAIN (2012)
Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination
Paris N. M. Sidiropoulos et al.
BRAIN (2012)
Molecular basis of axonal dysfunction and traffic impairments in CMT
Benoit J. Gentil et al.
BRAIN RESEARCH BULLETIN (2012)
Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth Disease
Byung-Ok Choi et al.
HUMAN MUTATION (2012)
Charcot-Marie-Tooth disease: Emerging mechanisms and therapies
Constantin d'Ydewalle et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Comparison between Clinical Disabilities and Electrophysiological Values in Charcot-Marie-Tooth 1A Patients with PMP22 Duplication
Young Hwa Kim et al.
JOURNAL OF CLINICAL NEUROLOGY (2012)
Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing
Sinead M. Murphy et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations
Anne Vital et al.
NEUROMUSCULAR DISORDERS (2012)
Exome Sequencing Identifies a DYNC1H1 Mutation in a Large Pedigree with Dominant Axonal Charcot-Marie-Tooth Disease
Michael N. Weedon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Charcot-Marie-Tooth Disease Subtypes and Genetic Testing Strategies
Anita S. D. Saporta et al.
ANNALS OF NEUROLOGY (2011)
High frequency of SH3TC2 mutations in Czech HMSN I patients
P. Lassuthova et al.
CLINICAL GENETICS (2011)
Charcot-Marie-Tooth caused by a copy number variation in myelin protein zero
Helle Hoyer et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2011)
Small Heat-Shock Protein HSPB1 Mutants Stabilize Microtubules in Charcot-Marie-Tooth Neuropathy
Leonardo Almeida-Souza et al.
JOURNAL OF NEUROSCIENCE (2011)
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
Davide Pareyson et al.
LANCET NEUROLOGY (2011)
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease
Constantin d'Ydewalle et al.
NATURE MEDICINE (2011)
SIMULTANEOUS MFN2 AND GDAP1 MUTATIONS CAUSE MAJOR MITOCHONDRIAL DEFECTS IN A PATIENT WITH CMT
J. Cassereau et al.
NEUROLOGY (2011)
MFN2 mutations cause severe phenotypes in most patients with CMT2A
S. M. E. Feely et al.
NEUROLOGY (2011)
TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies
C. J. Klein et al.
NEUROLOGY (2011)
A Major Determinant for Binding and Aminoacylation of tRNAAla in Cytoplasmic Alanyl-tRNA Synthetase Is Mutated in Dominant Axonal Charcot-Marie-Tooth Disease
Philippe Latour et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Compound Heterozygosity for Loss-of-Function Lysyl-tRNA Synthetase Mutations in a Patient with Peripheral Neuropathy
Heather M. McLaughlin et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
SH3TC2, a protein mutant in Charcot-Marie-Tooth neuropathy, links peripheral nerve myelination to endosomal recycling
Claudia Stendel et al.
BRAIN (2010)
Genetic and clinical aspects of Charcot-Marie-Tooth's disease
H. Skre
CLINICAL GENETICS (2010)
The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2K
C. Crimella et al.
JOURNAL OF MEDICAL GENETICS (2010)
Mitofusin 2 Is Necessary for Transport of Axonal Mitochondria and Interacts with the Miro/Milton Complex
Albert Misko et al.
JOURNAL OF NEUROSCIENCE (2010)
Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease
Rafael Sivera et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
COEXISTENCE OF TWO CHRONIC NEUROPATHIES IN A YOUNG CHILD: CHARCOT-MARIE-TOOTH DISEASE TYPE 1A AND CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Wilson Marques et al.
MUSCLE & NERVE (2010)
Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4
Han-Xiang Deng et al.
NATURE GENETICS (2010)
Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C
Guida Landoure et al.
NATURE GENETICS (2010)
CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene
D. -H. Chen et al.
NEUROLOGY (2010)
Whole-Genome Sequencing in a Patient with Charcot-Marie-Tooth Neuropathy.
James R. Lupski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Genome sequencing reveals Charcot-Marie-Tooth disease mutation
[Anonymous]
FUTURE NEUROLOGY (2010)
Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial
Camiel Verhamme et al.
BMC MEDICINE (2009)
Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial
Joshua Burns et al.
LANCET NEUROLOGY (2009)
Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randornised, double-blind, placebo-control led trial
Joelle Micallef et al.
LANCET NEUROLOGY (2009)
Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review) Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation
J. D. England et al.
NEUROLOGY (2009)
Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review) Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation
J. D. England et al.
NEUROLOGY (2009)
Charcot-Marie-Tooth (CMT) Disease 1A with Superimposed Inflammatory Polyneuropathy in Children
A. Desurkar et al.
NEUROPEDIATRICS (2009)
Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1 B mice
Maria Pennuto et al.
NEURON (2008)
Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (CMTX5)
Hee-Jin Kim et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Mechanisms of Disease: inherited demyelinating neuropathies - from basic to clinical research
Klaus-Armin Nave et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
Ascorbic acid inhibits PMP22 expression by reducing cAMP levels
Ferdinand Kaya et al.
NEUROMUSCULAR DISORDERS (2007)
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy
Gerd Meyer zu Horste et al.
ANNALS OF NEUROLOGY (2007)
Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: A potential therapy for inherited neuropathy
Mehrdad Khajavi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations
H. Azzedine et al.
NEUROLOGY (2006)
Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression
J Fortun et al.
NEUROBIOLOGY OF DISEASE (2006)
Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2
S Züchner et al.
ANNALS OF NEUROLOGY (2006)
Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy
A Jordanova et al.
NATURE GENETICS (2006)
Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease
A Niemann et al.
JOURNAL OF CELL BIOLOGY (2005)
NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients
Z Sahenk et al.
NEUROLOGY (2005)
Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease
E Passage et al.
NATURE MEDICINE (2004)
Coexistent hereditary and inflammatory neuropathy
L Ginsberg et al.
BRAIN (2004)
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
S Züchner et al.
NATURE GENETICS (2004)
Clinical, electrophysiological and morphological findings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene
T Sevilla et al.
BRAIN (2003)
Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V
A Antonellis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy
K Verhoeven et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C
VA Street et al.
NEUROLOGY (2003)
Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)
MW Sereda et al.
NATURE MEDICINE (2003)
Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy
J Senderek et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Mutations in GDAP1 -: Autosomal recessive CMT with demyelination and axonopathy
E Nelis et al.
NEUROLOGY (2002)
Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease:: Phenotypes linked by SOX10 mutation
K Inoue et al.
ANNALS OF NEUROLOGY (2002)
Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21
RV Baxter et al.
NATURE GENETICS (2002)
Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease 1A duplication
J Berciano et al.
NEUROMUSCULAR DISORDERS (2000)
A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene
IV Mersiyanova et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A
KM Krajewski et al.
BRAIN (2000)
Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies
MF Ritz et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Share Paper
